Y-mAbs Therapeutics Files 8-K: Material Agreement, FD Disclosure
| Field | Detail |
|---|---|
| Company | Y-Mabs Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, regulation-fd, financials
TL;DR
Y-mAbs signed a big deal, filed financials, and made an FD disclosure. Big news incoming.
AI Summary
On August 4, 2025, Y-mAbs Therapeutics, Inc. entered into a material definitive agreement. The company also provided a Regulation FD disclosure and filed financial statements and exhibits as part of this 8-K filing.
Why It Matters
This filing indicates a significant new agreement for Y-mAbs Therapeutics, potentially impacting its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce significant opportunities or risks depending on their terms and implications for the company's strategic direction.
Key Players & Entities
- Y-mAbs Therapeutics, Inc. (company) — Registrant
- August 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 202 Carnegie Center Suite 301 Princeton, NJ 08540 (address) — Principal executive offices
- 646-885-8505 (phone_number) — Registrant's Telephone Number
FAQ
What is the nature of the material definitive agreement entered into by Y-mAbs Therapeutics, Inc. on August 4, 2025?
The filing states that Y-mAbs Therapeutics, Inc. entered into a 'Material Definitive Agreement' on August 4, 2025, but the specific details of this agreement are not provided in the excerpt.
What other items are included in this 8-K filing?
This 8-K filing also includes a Regulation FD Disclosure and Financial Statements and Exhibits.
When was Y-mAbs Therapeutics, Inc. incorporated?
Y-mAbs Therapeutics, Inc. was incorporated in Delaware.
What is the principal business address of Y-mAbs Therapeutics, Inc.?
The principal business address is 202 Carnegie Center Suite 301, Princeton, NJ 08540.
What is the telephone number for Y-mAbs Therapeutics, Inc.?
The registrant's telephone number, including area code, is (646) 885-8505.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Y-mAbs Therapeutics, Inc..